Summary
Cencora, Inc. (COR) filed an 8-K on November 5, 2025, to announce its earnings for the fiscal quarter and year ended September 30, 2025. This filing also discloses a significant change in the company's reporting structure, effective from the first quarter of fiscal year 2026. The new structure will comprise three segments: U.S. Healthcare Solutions, International Healthcare Solutions, and Other. This reorganization aims to better align with Cencora's growth priorities and strategic drivers. Investors are provided with supplemental unaudited revised reportable segment information for fiscal years 2025 and 2024 under the new structure to facilitate analysis. The company also announced a conference call and webcast to discuss these results and related matters. The "Other" segment will house businesses for which strategic alternatives are being explored, including MWI Animal Health and U.S. Consulting Services, which could be of particular interest to investors monitoring divestiture or strategic partnership activities.
Key Highlights
- 1Cencora announced its financial results for the fiscal quarter and year ended September 30, 2025.
- 2A new reporting structure will be implemented starting Q1 FY2026, comprising U.S. Healthcare Solutions, International Healthcare Solutions, and Other.
- 3The "Other" segment includes businesses where strategic alternatives are being explored, such as MWI Animal Health and U.S. Consulting Services.
- 4Supplemental unaudited revised segment data for FY2025 and FY2024 is being provided under the new reporting structure.
- 5The company will host a conference call and webcast on November 5, 2025, to discuss its financial performance and strategic changes.
- 6The filing includes the earnings release (Exhibit 99.1) and revised segment information (Exhibit 99.2).